Sio Capital Management, LLC - Q4 2019 holdings

$420 Million is the total value of Sio Capital Management, LLC's 69 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 212.5% .

 Value Shares↓ Weighting
ITCI NewINTRA-CELLULAR THERAPIES INCput$66,795,0001,946,800
+100.0%
15.91%
GWPH BuyGW PHARMACEUTICALS PLCads$19,423,000
-6.0%
185,757
+3.4%
4.63%
-30.5%
CHRS BuyCOHERUS BIOSCIENCES INC$17,046,000
+39.1%
946,761
+56.5%
4.06%
+2.9%
MDT BuyMEDTRONIC PLC$16,680,000
+90.3%
147,022
+82.2%
3.97%
+40.7%
MRK NewMERCK & CO INC$15,439,000169,755
+100.0%
3.68%
PFE BuyPFIZER INC$14,923,000
+45.0%
380,874
+33.0%
3.55%
+7.2%
CVM BuyCEL-SCI CORPput$13,978,000
+124.8%
1,527,600
+119.6%
3.33%
+66.2%
GILD NewGILEAD SCIENCES INC$12,086,000186,000
+100.0%
2.88%
UTHR BuyUNITED THERAPEUTICS CORP$11,685,000
+67.1%
132,664
+51.3%
2.78%
+23.6%
MOH BuyMOLINA HEALTHCARE INC$9,937,000
+178.7%
73,236
+125.4%
2.37%
+106.2%
GSK NewGLAXOSMITHKLINE PLCsponsored adr$9,619,000204,705
+100.0%
2.29%
MCK BuyMCKESSON CORP$9,466,000
+9.6%
68,439
+8.3%
2.26%
-18.9%
ABC BuyAMERISOURCEBERGEN CORP$9,458,000
+11.4%
111,249
+7.9%
2.25%
-17.6%
ANTM BuyANTHEM INC$9,284,000
+41.7%
30,739
+12.7%
2.21%
+4.8%
SNY NewSANOFI SAsponsored adr$8,583,000170,977
+100.0%
2.04%
MEIP BuyMEI PHARMA INC$5,949,000
+1267.6%
2,398,852
+826.7%
1.42%
+912.1%
IMVT NewIMMUNOVANT INC*w exp 12/18/2024$5,483,000615,400
+100.0%
1.31%
MMSI NewMERIT MEDICAL SYSTEMS INC$4,683,000150,000
+100.0%
1.12%
ARDX NewARDELYX INC$4,665,000621,534
+100.0%
1.11%
ARNA BuyARENA PHARMACEUTICALS INC$4,059,000
+102.2%
89,357
+103.7%
0.97%
+49.7%
ESPR NewESPERION THERAPEUTICS INC$3,379,00056,658
+100.0%
0.80%
SYRS NewSYROS PHARMACEUTICALS INC$3,099,000448,532
+100.0%
0.74%
SAGE NewSAGE THERAPEUTICS INCput$3,025,00041,900
+100.0%
0.72%
NewTRILLIUM THERAPEUTICS INC$2,834,0002,751,186
+100.0%
0.68%
AFMD NewAFFIMED NV$2,790,0001,018,200
+100.0%
0.66%
HROW BuyHARROW HEALTH INC$2,684,000
+41.0%
344,940
+1.9%
0.64%
+4.2%
PFNX BuyPFENEX INC$2,554,000
+56.3%
232,626
+20.2%
0.61%
+15.6%
ZFGN NewZAFGEN INC$2,534,0002,283,164
+100.0%
0.60%
ASLN NewASLAN PHARMACEUTICALS LTDads$2,066,0001,017,971
+100.0%
0.49%
RDUS NewRADIUS HEALTH INC$2,016,000100,000
+100.0%
0.48%
WVE NewWAVE LIFE SCIENCES LTDcall$1,756,000219,100
+100.0%
0.42%
PHG NewKONINKLIJKE PHILIPS NVput$1,649,00033,800
+100.0%
0.39%
ARAV NewARAVIVE INC$1,342,00098,201
+100.0%
0.32%
BCEL NewATRECA INC$1,320,00085,312
+100.0%
0.31%
BEAT NewBIOTELEMETRY INCput$1,306,00028,200
+100.0%
0.31%
PGNY NewPROGYNY INC$1,233,00044,910
+100.0%
0.29%
ARVN NewARVINAS INC$1,235,00030,052
+100.0%
0.29%
OPK NewOPKO HEALTH INC$1,184,000805,311
+100.0%
0.28%
SPPI BuySPECTRUM PHARMACEUTICALS INCcall$1,133,000
-53.3%
311,400
+6.4%
0.27%
-65.5%
OVID NewOVID THERAPEUTICS INC$1,098,000264,581
+100.0%
0.26%
NLTX NewNEOLEUKIN THERAPEUTICS INC$1,086,00088,185
+100.0%
0.26%
MRSN NewMERSANA THERAPEUTICS INC$953,000166,250
+100.0%
0.23%
ABEO NewABEONA THERAPEUTICS INC$924,000282,520
+100.0%
0.22%
LOGC BuyLOGICBIO THERAPEUTICS INC$906,000
-31.6%
125,836
+2.7%
0.22%
-49.4%
KRTX NewKARUNA THERAPEUTICS INC$722,0009,588
+100.0%
0.17%
DTIL NewPRECISION BIOSCIENCES INC$603,00043,433
+100.0%
0.14%
LPTX NewLEAP THERAPEUTICS INC$533,000476,223
+100.0%
0.13%
CMD NewCANTEL MEDICAL CORPput$518,0007,300
+100.0%
0.12%
MTD NewMETTLER-TOLEDO INTERNATIONAL INCput$317,000400
+100.0%
0.08%
NewAPTOSE BIOSCIENCES INC$284,00050,000
+100.0%
0.07%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VIKING THERAPEUTICS INC24Q3 20233.4%
UNITED THERAPEUTICS ORD23Q3 20238.3%
CARDINAL HEALTH ORD20Q2 20227.2%
SANOFI SA19Q3 20229.8%
MEDTRONIC PLC18Q3 20235.2%
CATALYST BIOSCIENCES INC18Q3 202117.8%
PFENEX ORD18Q4 20195.9%
AEGLEA BIOTHERAPEUTICS INC18Q1 20231.1%
HCA HEALTHCARE INC17Q2 20225.5%
MCKESSON ORD17Q1 20226.0%

View Sio Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Sio Capital Management, LLC Q4 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Modular Medical, Inc.February 13, 20231,091,47910.0%
Cellectar Biosciences, Inc.February 10, 2022? ?
CURIS INCFebruary 10, 20223,866,6454.2%
Salarius Pharmaceuticals, Inc.February 10, 20221,354,2913.0%
Larimar Therapeutics, Inc.February 16, 2021188,6611.2%
ACHIEVE LIFE SCIENCES, INC.February 14, 2020? ?
Bionano Genomics, IncFebruary 14, 20201,210,8214.6%
Brickell Biotech, Inc.February 14, 2020? ?
Trillium Therapeutics Inc.February 14, 20202,751,1869.8%
ZAFGEN, INC.February 14, 20202,283,1646.1%

View Sio Capital Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-12
13F-HR2023-02-13
SC 13G2023-02-13

View Sio Capital Management, LLC's complete filings history.

Compare quarters

Export Sio Capital Management, LLC's holdings